发明名称 |
COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS |
摘要 |
The present application relates to compositions of chimeric anti-endoglin antibodies and anti-VEGF agents. Another aspect relates to the use of chimeric anti-endoglin antibodies and Bevacizumab. Another aspect relates to the use of the compositions to inhibit VEGF induced sprouting. Another aspect relates to the use of the compositions to inhibit angiogenesis. |
申请公布号 |
US2012244147(A1) |
申请公布日期 |
2012.09.27 |
申请号 |
US201013390896 |
申请日期 |
2010.08.16 |
申请人 |
THEUER CHARLES P.;SEON BEN K. |
发明人 |
THEUER CHARLES P.;SEON BEN K. |
分类号 |
A61K39/395;A61P1/00;A61P19/02;A61P27/02;A61P29/00;A61P35/00;C12N5/02 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|